Nachtergael Ingrid, Vertongen Pascale, Langer Ingrid, Perret Jason, Robberecht Patrick, Waelbroeck Magali
Department of Biochemistry and Nutrition, School of Medicine, Université Libre de Bruxelles, Bât G/E, CP 611, 808 route de Lennik, B-1070 Bruxelles, Belgium.
Biochem J. 2003 Mar 15;370(Pt 3):1003-9. doi: 10.1042/BJ20020811.
We developed previously VPAC(1) [vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP) receptor]>VPAC(2) receptor selective ligands. Replacement of the VIP-Thr(11) by an Arg(11) in these ligands contributed to their selectivity: Arg(11)-VIP had a 200-fold lower affinity when compared with VIP at VPAC(2) receptors as opposed to 3- to 5-fold higher affinity at VPAC(1) receptors. Comparison of the binding and functional properties of related VIP analogues suggested that the VPAC(1) selectivity of Arg(11)-VIP was due to the loss of a hydrogen bond between the hydroxy group of Thr residue and the VPAC(2) receptor, steric hindrance between the Arg side chain and the VPAC(2) receptor and charge attraction by the VPAC(1) receptor. Comparison of the ability of VIP analogues to activate adenylate cyclase through chimaeric VPAC(1)/VPAC(2) and VPAC(2)/VPAC(1) receptors indicated that the first extracellular receptor loop carried most of the VPAC(2) receptors' ability to discriminate VIP from Arg(11)-VIP. Based on results obtained for a truncated VPAC(2) receptor and the closely related PACAP-preferring receptor (PAC(1)) and secretin receptors, we hypothesized that Thr(11) interacted with the VPAC(2) receptor Tyr(184) (similar to the VPAC(1) receptor Phe(200) residue). The Y184F (Tyr(184)-->Phe) VPAC(2) mutant lost the ability to discriminate VIP from Val(11)-VIP, and the F200Y VPAC(1) mutant acquired the ability to discriminate the natural peptide from Val(11)-VIP. These results support the hypothesis that the hydroxy group of the native VIP-Thr(11) side chain can indeed form a hydrogen bond with the Tyr side chain in the VPAC(2) receptor.
我们之前开发了VPAC(1) [血管活性肠肽(VIP)/垂体腺苷酸环化酶激活肽(PACAP)受体]>VPAC(2)受体选择性配体。在这些配体中用精氨酸(Arg(11))取代VIP的苏氨酸(Thr(11))有助于其选择性:与VIP相比,Arg(11)-VIP在VPAC(2)受体上的亲和力低200倍,而在VPAC(1)受体上的亲和力高3至5倍。相关VIP类似物的结合和功能特性比较表明,Arg(11)-VIP对VPAC(1)的选择性是由于苏氨酸残基的羟基与VPAC(2)受体之间氢键的丧失、精氨酸侧链与VPAC(2)受体之间的空间位阻以及VPAC(1)受体的电荷吸引。VIP类似物通过嵌合的VPAC(1)/VPAC(2)和VPAC(2)/VPAC(1)受体激活腺苷酸环化酶的能力比较表明,第一个细胞外受体环承载了VPAC(2)受体区分VIP和Arg(11)-VIP的大部分能力。基于截短的VPAC(2)受体以及密切相关的偏好PACAP的受体(PAC(1))和促胰液素受体的结果,我们推测Thr(11)与VPAC(2)受体的Tyr(184)相互作用(类似于VPAC(1)受体的Phe(200)残基)。Y184F (Tyr(184)→Phe) VPAC(2)突变体失去了区分VIP和Val(11)-VIP的能力,而F200Y VPAC(1)突变体获得了区分天然肽和Val(11)-VIP的能力。这些结果支持了这样的假设,即天然VIP-Thr(11)侧链的羟基确实可以与VPAC(2)受体中的酪氨酸侧链形成氢键。